ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
Immucell stock last closed at $5.38, down 2.18% from the previous day, and has increased 6.96% in one year. It has overperformed other stocks in the Biotechnology industry by 0.85 percentage points. Immucell stock is currently +61.08% from its 52-week low of $3.34, and -7.56% from its 52-week high of $5.82.
At the moment, there are 8.98M shares of ICCC outstanding. The market value of ICCC is $48.33M. In the past 24 hours, 5187 ICCC shares were traded.
You need an online brokerage account to access the NASDAQ market and buy ICCC shares.
Based on our research, eToro is the best stock brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the best brokerage, it's time to fill out some personal details so you are able to buy ICCC stock today.
Now that you've filled out your info on one of the best stock trading apps, you can securely and quickly fund your account:
Check out the video below if you need help transferring funds into your brokerage account.
Once you have chosen the best place to buy Immucell stock, it's important to research their stock before you invest, so you actually wrap your head around the risk and opportunity.
WallStreetZen was created to help everyday investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on ICCC's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge ICCC's fair value.
Using relative valuations methods:
You can access additional valuation research on ICCC's stock here.
Last year, ICCC revenue was $26.49M. In the past 5 year, ICCC's revenue has grown by 14.06% per year. This was slower than the Biotechnology industry average of 44.31%.
Dig into ICCC's earnings and revenue performance here.
Over the last year, executives and large shareholders at ICCC have bought more shares than they have sold.
David Scott Tomsche, Director of ICCC, was the latest ICCC insider to buy. They bought $7,760.30 worth of ICCC stock on Aug 28, 2024.
Get more info about who owns ICCC shares here.
No, Immucell doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two main options:
Hit the Open button and your broker will execute your order.
If you require more help with investing in stocks on eToro, watch the how to video below:
Now that you own some shares in ICCC, you'll want to keep up with your stock purchase.
Add ICCC to a watchlist to get the latest updates about your ICCC stock.
To summarize, here are the 6 steps you need to take to buy Immucell stock right now:
If you need a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Immucell, create your watchlist below.